hat
NCT02484092. Terapi jèn, Open-Label, etid Dòz-Eskalasyon nan SPK-9001 [Adeno-Associated vektè viral Avèk Imèn moun faktè IX] Nan sijè ki gen emofil B. https://clinicaltrials.gov/ct2/show/NCT02484092
eng
NCT02484092. Gene Therapy, Open-Label, Dose-Escalation Study of SPK-9001 [Adeno-Associated Viral Vector With Human Factor IX Gene] In Subjects With Hemophilia B. https://clinicaltrials.gov/ct2/show/NCT02484092